Add to bookmarks
Neuromuscular monitoring in 2024: are we practising to the highest possible standards?

The pharmacology of reversal agents: their benefits and side-effects

Speakers

Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on neuromuscular monitoring in 2024. In this second part, Dr. J. Ross Renew MD FASA FASE, Mayo Clinic, Florida, will review the pharmacology of reversal agents discussing their benefits and side-effects.

This webinar was sponsored by GE HealthCare.

Dr. J. Joss Renew

Dr. J. Ross Renew

J. Ross Renew MD FASA FASE graduated from Clemson University (Chemistry, BS) and completed medical school at the University of South Carolina School of Medicine.  Dr. Renew completed anesthesia residency at Mayo Clinic Florida and his fellowship in Adult Cardiothoracic Anesthesiology at Mayo Clinic in Rochester, MN.  Dr. Renew then returned to Jacksonville and has worked on staff at Mayo Clinic Florida where he is currently an Assistant Professor of Anesthesiology.  Dr. Renew serves as the Vice Chair of Research and Associate Program Director for the department’s residency program.  His research interests involve neuromuscular blockade and monitoring, transesophageal echocardiography, and caring for the cardiac patient undergoing non-cardiac surgery.